N@N

FOLD, SCMP, OUTD, ALTI, TSON, PRM Expected To Be Lower After Earnings Releases on Thursday

^{Published on 2010-08-04 07:28:23, Last Modified on 2010-12-22 18:40:18 - WOPRAI}
 

August 4, 2010 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, August 5th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and August earnings reports. Amicus Therapeutics (NASDAQ: FOLD), Sucampo Pharmaceuticals (NASDAQ: SCMP), Outdoor Channel Holdings (NASDAQ: OUTD), Altair Nanotechnologies (NASDAQ: ALTI), TranS1 (NASDAQ: TSON) and PRIMEDIA (NYSE: PRM) are all expected to be lower after their earnings are released Thursday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go lower after earnings are released Thursday:

SymbolCompany# of ReportsQuarterRelease Time FOLDAmicus Therapeutics, Inc.12 quartersQ2After SCMPSucampo Pharmaceuticals, Inc.12 quartersQ2After OUTDOutdoor Channel Holdings Inc.August earningsQ2After ALTIAltair Nanotechnologies Inc12 quartersQ2Before TSONTranS1 Inc.12 quartersQ2After PRMPRIMEDIA, Inc.12 quartersQ2Before

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Amicus Therapeutics Inc. (NASDAQ: FOLD) a pharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs for the treatment of various human genetic diseases. Its drugs are known as pharmacological chaperones, which selectively bind to the target protein, increase the stability of the protein, help it fold into the three-dimensional shape, and allow proper trafficking of the protein, thereby increasing protein activity, enhance cellular function, and reduce cell stress. The company primarily focuses on lysosomal storage disorders and diseases of neurodegeneration. Its lead product candidate includes Amigal, which is in Phase III development for the treatment of Fabry disease. The company also develops AT2220, which is in Phase I testing for the treatment of Pompe disease. In addition, it develops Plicera for the treatment of Gaucher disease. The company was founded in 2002 and is based in Cranbury, New Jersey.

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs based on prostones primarily in the Americas, Europe, and Asia. It offers prostone-based compounds for the treatment of gastrointestinal, vascular, respiratory, and central nervous system diseases and disorders. The company primarily markets Amitiza for the treatment of chronic idiopathic constipation in adults, as well as for irritable bowel syndrome with constipation in adult women. It also offers Rescula (unoprostone isopropyl) for the treatment of open-angle glaucoma and ocular hypertension. In addition, the company is developing Amitiza for the treatment of opioid-induced bowel dysfunction, which completed two Phase III clinical trials; Cobiprostone for the prevention of non-steroidal anti-inflammatory drug induced ulcers, which completed a Phase IIa clinical trial; SPI-017, a Phase I clinical trial product, for the treatment of Peripheral arterial disease; and SPI-3608 for the treatment of spinal stenosis, which is under preclinical trial. Additionally, it is conducting a preclinical trial of Rescula for dry age related macular degeneration; and preclinical trials of Cobiprostone for the treatment of chronic obstructive pulmonary disease and wound healing. Sucampo Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.

Outdoor Channel Holdings, Inc. (NASDAQ: OUTD), through its subsidiaries, operates as an entertainment and media company in the United States. The company operates in two segments, The Outdoor Channel and Production Services. The Outdoor Channel segment operates Outdoor Channel, a national television network that focuses on traditional outdoor related lifestyle programming. It focuses on various traditional outdoor activities, such as hunting, fishing, and shooting sports, as well as off-road motor sports and other outdoor related lifestyle programming. This segment primarily serves sportsmen and outdoor enthusiasts. The Production Services segment engages in the production, development, and marketing of sports programming. This segment produces various programs for the companya�s network or for third parties, including bowling, rodeo, golf, softball, hunting, and fishing. It also operates as an advertising and sponsorship representative; and provides various marketing services, including traditional agency services and Web services. In addition, this segment designs, manufactures, and operates suspended mobile aerial camera systems. The company was founded in 1984 and is headquartered in Temecula, California.

Altair Nanotechnologies, Inc. (NASDAQ: ALTI) develops, manufactures, and sells rechargeable lithium ion batteries in the United States and internationally. It offers nano lithium titanate battery cells, batteries, and battery packs, as well as provides related design, installation, and test services. The company also provides contract research services to develop intellectual property and/or new products and technology. It markets its energy storage solutions to power companies and electric grid operators, as well as battery products to the electric and hybrid-electric mass-transit markets. The company was formerly known as Altair International Inc. and changed its name to Altair Nanotechnologies, Inc. in July 2002. Altair Nanotechnologies, Inc. was founded in 1973 and is headquartered in Reno, Nevada.

TranS1 Inc. (NASDAQ: TSON), a medical device company, focuses on the design, development, and marketing of products that implement its proprietary surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine. The company offers TranS1 pre-sacral approach that enables spine surgeons to access and treat degenerative lumbar discs, as well as to perform fusion and motion preserving surgeries in the L4/L5/S1 region. Its products include AxiaLIF lumbar fusion implant, a threaded titanium rod to enable one-level L5/S1 fusions and two-level L4/L5/S1 fusions; AxiaLIF 360 implants, which consist of 3D Axial Rod plus its titanium facet screws for supplemental posterior fixation; and TranS1 access and disc preparation instruments. In addition, the company, through a partnership agreement with Life Spine, Inc., distributes Avatar, a minimally invasive pedicle screw system. It markets and sells its products through direct sales representatives and independent sales agents in the United States, as well as primarily through third-party distributors in Europe. The company was formerly known as aXiaMed, Inc. and changed its name to TranS1 Inc. in February 2003. TranS1 Inc. was founded in 2000 and is headquartered in Wilmington, North Carolina.

PRIMEDIA Inc. (NYSE: PRM), together with its subsidiaries, engages in the production and distribution of consumer directories primarily for the apartment and other rental property sectors of the residential real estate industry through online, print, and mobile platforms. The companya�s principal digital assets include ApartmentGuide.com that delivers apartment and apartment community rental information to consumers through a combination of Internet, print, and mobile products and services; Rentals.com, a real estate rental site with various collections of single-unit rental property listings on the Internet; RentalHouses.com; NewHomeGuide.com; and AmericanHomeGuides.com. As of December 31, 2009 it distributed approximately 14.9 million printed directories to approximately 17,000 advertiser client locations and 28,000 retail and other locations. The company was formerly known as K-III Communications Corporation and changed its name to PRIMEDIA Inc. in 1997. PRIMEDIA Inc. was founded in 1989 and is headquartered in Norcross, Georgia.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641